Literature DB >> 869013

Changes in bone and bone marrow of rabbits bearing the VX-2 carcinoma. A comparison of local and distant effects.

A Hough, H Seyberth, J Oates, W Hartmann.   

Abstract

The VX-2 carcinoma in 32 New Zealand white rabbits was studied morphologically with respect to the osseous effects induced by the innoculation and subsequent growth of tumour in the soft tissues over periods ranging from 1 to 5 weeks. Although more severe changes were noted in bones of tumor-bearing than in non-tumor-bearing limbs, effects could be seen in both experimental situations. Severe bone marrow hyperplasia was noted consistently in tumor-bearing animals. A marked increase in numbers of osteoclasts over control rabbit bones was observed along the surface of bones near and distant from the tumor. Resorptive changes were also noted in the cortex of tumor-bearing rabbits. The increase in osteoclast numbers was related chronologically to the development of hypercalcemia and was proportional to the degree of hypercalcemia at the time the animals died. The number of osteoclasts was inversely proportional to the serum creatinine. A diminution of osteoclast numbers was noted in the latter stages of the disease. These changes may be the morphologic expression of humoral hypercalcemia accompanying the VX-2 carcinoma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 869013      PMCID: PMC2032139     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  HYPERPARATHYROID-LIKE STATE IN RABBITS WITH THE VX-2 CARCINOMA: FURTHER STUDIES.

Authors:  J R WILSON; H MERRICK; S D VOGEL; E R WOODWARD
Journal:  Am Surg       Date:  1965-02       Impact factor: 0.688

2.  A STUDY OF THE LEUKEMOID RESPONSE TO TRANSPLANTABLE A-280 TUMOR IN MICE.

Authors:  E J LAPPAT; M CAWEIN
Journal:  Cancer Res       Date:  1964-02       Impact factor: 12.701

3.  Response of bone to tumor invasion.

Authors:  R A MILCH; G W CHANGUS
Journal:  Cancer       Date:  1956 Mar-Apr       Impact factor: 6.860

4.  Hypercalcemia in bronchogenic carcinoma. A prospective study of 200 patients.

Authors:  R A Bender; H Hansen
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

5.  Lung cancer: a transmission and scanning electron microscopic study.

Authors:  A Lupulescu; C B Boyd
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

6.  Prostaglandins: stimulation of bone resorption in tissue culture.

Authors:  D C Klein; L G Raisz
Journal:  Endocrinology       Date:  1970-06       Impact factor: 4.736

7.  A method for the preparation of undecalcified bone sections for light microscopy and microradiography.

Authors:  J Xipell; H Makin; P McKinnon
Journal:  Stain Technol       Date:  1974-03

8.  Prostaglandins, calcium metabolism and cancer.

Authors:  A H Tashjian; E F Voelkel; P Goldhaber; L Levine
Journal:  Fed Proc       Date:  1974-01

9.  Hypercalcemia and malignant disease.

Authors:  D Chopra; E P Clerkin
Journal:  Med Clin North Am       Date:  1975-03       Impact factor: 5.456

10.  Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.

Authors:  A H Tashjian; E F Voelkel; L Levine; P Goldhaber
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.

Authors:  H W Seyberth
Journal:  Klin Wochenschr       Date:  1978-04-15

2.  Hypercalcemia of malignancy. Animal model: VX-2 carcinoma of rabbits.

Authors:  D M Young; J M Ward; D J Prieur
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

3.  Leydig cell tumor induced hypercalcemia in the Fischer rat: morphometric and histochemical evidence for a humoral factor that activates osteoclasts.

Authors:  H Troyer; J R Sowers; E Babich
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

4.  VX2 carcinoma, pulmonary metastases, and neutrophilic leukocytosis. Possible animal model of tumor-associated granulocytosis.

Authors:  A J Hough; W C Hubbard; J A Oates
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

5.  Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration.

Authors:  S A Curley; D L Stone; G M Fuhrman; D C Hohn; Z H Siddik; R A Newman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Ultrastructural evaluation of adenocarcinomas derived from apocrine glands of the anal sac associated with hypercalcemia in dogs.

Authors:  D J Meuten; C C Capen; G J Kociba; D J Chew; B J Cooper
Journal:  Am J Pathol       Date:  1982-05       Impact factor: 4.307

7.  Transcatheter arterial embolization as a method of cisplatin-retention enhancement on the VX2 tumor uterus transplants.

Authors:  K Harima; Y Harima; T Hasegawa; Y Tanaka
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jan-Feb       Impact factor: 2.740

8.  Doxorubicin treatment of rabbit renal VX-2 carcinoma: nephrotoxicity, serum parameters and weight.

Authors:  G Gadeholt-Göthlin; H Vik; J H Göthlin
Journal:  Urol Res       Date:  1995

9.  Some mechanisms of local bone destruction by squamous carcinomas of the head and neck.

Authors:  S W Tsao; J F Burman; D M Easty; G C Easty; R L Carter
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

Review 10.  Animal Models of Cancer-Associated Hypercalcemia.

Authors:  Nicole A Kohart; Said M Elshafae; Justin T Breitbach; Thomas J Rosol
Journal:  Vet Sci       Date:  2017-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.